Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS - PubMed (original) (raw)
. 2005 Jul;128(Pt 7):1686-706.
doi: 10.1093/brain/awh503. Epub 2005 May 4.
Affiliations
- PMID: 15872021
- DOI: 10.1093/brain/awh503
Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS
Janine Kirby et al. Brain. 2005 Jul.
Abstract
Familial amyotrophic lateral sclerosis (FALS) is caused, in 20% of cases, by mutations in the Cu/Zn superoxide dismutase gene (SOD1). Although motor neuron injury occurs through a toxic gain of function, the precise mechanism(s) remains unclear. Using an established NSC34 cellular model for SOD1-associated FALS, we investigated the effects of mutant SOD1 specifically in cells modelling the vulnerable cell population, the motor neurons, without contamination from non-neuronal cells present in CNS. Using gene expression profiling, 268 transcripts were differentially expressed in the presence of mutant human G93A SOD1. Of these, 197 were decreased, demonstrating that the presence of mutant SOD1 leads to a marked degree of transcriptional repression. Amongst these were a group of antioxidant response element (ARE) genes encoding phase II detoxifying enzymes and antioxidant response proteins (so-called 'programmed cell life' genes), the expression of which is regulated by the transcription factor NRF2. We provide evidence that dysregulation of Nrf2 and the ARE, coupled with reduced pentose phosphate pathway activity and decreased generation of NADPH, represent significant and hitherto unrecognized components of the toxic gain of function of mutant SOD1. Other genes of interest significantly altered in the presence of mutant SOD1 include several previously implicated in neurodegeneration, as well as genes involved in protein degradation, the immune response, cell death/survival and the heat shock response. Preliminary studies on isolated motor neurons from SOD1-associated motor neuron disease cases suggest key genes are also differently expressed in the human disease.
Similar articles
- Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Jeon GS, Shim YM, Lee DY, Kim JS, Kang M, Ahn SH, Shin JY, Geum D, Hong YH, Sung JJ. Jeon GS, et al. Mol Neurobiol. 2019 Mar;56(3):2007-2021. doi: 10.1007/s12035-018-1218-2. Epub 2018 Jul 7. Mol Neurobiol. 2019. PMID: 29982983 Free PMC article. - Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis.
Menzies FM, Cookson MR, Taylor RW, Turnbull DM, Chrzanowska-Lightowlers ZM, Dong L, Figlewicz DA, Shaw PJ. Menzies FM, et al. Brain. 2002 Jul;125(Pt 7):1522-33. doi: 10.1093/brain/awf167. Brain. 2002. PMID: 12077002 - Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress.
Cookson MR, Menzies FM, Manning P, Eggett CJ, Figlewicz DA, McNeil CJ, Shaw PJ. Cookson MR, et al. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002 Jun;3(2):75-85. doi: 10.1080/146608202760196048. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002. PMID: 12215229 - Gene expression profiling toward understanding of ALS pathogenesis.
Tanaka F, Niwa J, Ishigaki S, Katsuno M, Waza M, Yamamoto M, Doyu M, Sobue G. Tanaka F, et al. Ann N Y Acad Sci. 2006 Nov;1086:1-10. doi: 10.1196/annals.1377.011. Ann N Y Acad Sci. 2006. PMID: 17185501 Review. - [Familial amyotrophic lateral sclerosis and mutations in the Cu/Zn superoxide dismutase gene].
Nakano R. Nakano R. Rinsho Shinkeigaku. 1995 Dec;35(12):1546-8. Rinsho Shinkeigaku. 1995. PMID: 8752459 Review. Japanese.
Cited by
- Mitochondrial Medicine: A Promising Therapeutic Option Against Various Neurodegenerative Disorders.
Almikhlafi MA, Karami MM, Jana A, Alqurashi TM, Majrashi M, Alghamdi BS, Ashraf GM. Almikhlafi MA, et al. Curr Neuropharmacol. 2023;21(5):1165-1183. doi: 10.2174/1570159X20666220830112408. Curr Neuropharmacol. 2023. PMID: 36043795 Free PMC article. Review. - Molecular and Cellular Mechanisms Affected in ALS.
Le Gall L, Anakor E, Connolly O, Vijayakumar UG, Duddy WJ, Duguez S. Le Gall L, et al. J Pers Med. 2020 Aug 25;10(3):101. doi: 10.3390/jpm10030101. J Pers Med. 2020. PMID: 32854276 Free PMC article. Review. - SMN protects cells against mutant SOD1 toxicity by increasing chaperone activity.
Zou T, Ilangovan R, Yu F, Xu Z, Zhou J. Zou T, et al. Biochem Biophys Res Commun. 2007 Dec 28;364(4):850-5. doi: 10.1016/j.bbrc.2007.10.096. Epub 2007 Oct 25. Biochem Biophys Res Commun. 2007. PMID: 17964281 Free PMC article. - Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis.
Kirby J, Ning K, Ferraiuolo L, Heath PR, Ismail A, Kuo SW, Valori CF, Cox L, Sharrack B, Wharton SB, Ince PG, Shaw PJ, Azzouz M. Kirby J, et al. Brain. 2011 Feb;134(Pt 2):506-17. doi: 10.1093/brain/awq345. Epub 2011 Jan 12. Brain. 2011. PMID: 21228060 Free PMC article. - Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis.
Pitzer C, Krüger C, Plaas C, Kirsch F, Dittgen T, Müller R, Laage R, Kastner S, Suess S, Spoelgen R, Henriques A, Ehrenreich H, Schäbitz WR, Bach A, Schneider A. Pitzer C, et al. Brain. 2008 Dec;131(Pt 12):3335-47. doi: 10.1093/brain/awn243. Epub 2008 Oct 3. Brain. 2008. PMID: 18835867 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous